Voloridge Investment Management, LLC Beam Therapeutics Inc. Transaction History

Voloridge Investment Management, LLC

  • $26.2 Billion
  • Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 463,662 shares of BEAM stock, worth $13.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
463,662
Previous 382,995 21.06%
Holding current value
$13.3 Million
Previous $8.97 Million 26.59%
% of portfolio
0.04%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$22.57 - $33.14 $1.82 Million - $2.67 Million
80,667 Added 21.06%
463,662 $11.4 Million
Q2 2024

Aug 14, 2024
BUY
$21.22 - $32.66 $3.11 Million - $4.79 Million
146,608 Added 62.02%
382,995 $8.97 Million
Q1 2024

May 15, 2024
BUY
$23.46 - $45.07 $1.83 Million - $3.52 Million
78,139 Added 49.38%
236,387 $7.81 Million
Q4 2023

Feb 14, 2024
BUY
$17.69 - $30.76 $2.8 Million - $4.87 Million
158,248 New
158,248 $4.31 Million
Q2 2023

Aug 14, 2023
SELL
$29.32 - $35.99 $869,484 - $1.07 Million
-29,655 Reduced 50.42%
29,161 $931,000
Q1 2023

May 15, 2023
BUY
$30.15 - $48.79 $386,523 - $625,487
12,820 Added 27.87%
58,816 $1.8 Million
Q4 2022

Feb 14, 2023
SELL
$36.73 - $51.6 $6.18 Million - $8.68 Million
-168,224 Reduced 78.53%
45,996 $1.8 Million
Q3 2022

Nov 14, 2022
SELL
$39.79 - $70.31 $4.47 Million - $7.89 Million
-112,274 Reduced 34.39%
214,220 $10.2 Million
Q2 2022

Aug 15, 2022
BUY
$29.86 - $62.36 $7.43 Million - $15.5 Million
248,897 Added 320.76%
326,494 $12.6 Million
Q1 2022

May 16, 2022
BUY
$53.73 - $82.16 $3.31 Million - $5.06 Million
61,595 Added 384.92%
77,597 $4.45 Million
Q4 2021

Feb 14, 2022
BUY
$68.02 - $99.06 $244,327 - $355,823
3,592 Added 28.94%
16,002 $1.28 Million
Q3 2021

Nov 15, 2021
SELL
$84.37 - $133.6 $18.7 Million - $29.7 Million
-222,044 Reduced 94.71%
12,410 $1.08 Million
Q2 2021

Aug 16, 2021
SELL
$64.12 - $128.71 $653,190 - $1.31 Million
-10,187 Reduced 4.16%
234,454 $30.2 Million
Q1 2021

May 17, 2021
BUY
$71.28 - $120.75 $4.83 Million - $8.19 Million
67,793 Added 38.33%
244,641 $19.6 Million
Q4 2020

Feb 16, 2021
BUY
$22.24 - $95.63 $3.93 Million - $16.9 Million
176,848 New
176,848 $14.4 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.01B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email